Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.51 |
| ▸ | DRD4 | P21917 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 10/20 | 0.50 |
| ▸ | CA12 | O43570 | 9/20 | 0.50 |
| ▸ | CA1 | P00915 | 9/20 | 0.50 |
| ▸ | CA9 | Q16790 | 5/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | OGA | O60502 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 5/20 | 0.45 |
| ▸ | CA5A | P35218 | 5/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5489564 | 1.00 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL9614389 | 1.00 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL9614375 | 1.00 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL1357029 | 1.00 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL3794903 | 1.00 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL13713745 | 1.00 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL16946235 | 1.00 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL3794899 | 1.00 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL14342159 | 1.00 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL8908686 | 0.89 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10TSHRNR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8242062-B2 | IMS detection of chemical markers in petroleum products | AUTHENTIX, INC. (US) | 2012-08-14 | — | — | US | disclosed |
| US-20110262977-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINE DERIVATIVE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-10-27 | — | — | US | disclosed |
| EP-2330210-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINE DERIVATIVE | Daicel Chemical Industries, Ltd. (JP) | 2011-06-08 | — | — | EP | disclosed |
| US-20070212785-A1 | IMS DETECTION OF CHEMICAL MARKERS IN PETROLEUM PRODUCTS | AUTHENTIX, INC. (US) | 2007-09-13 | — | — | US | disclosed |
| US-7208451-B2 | IMS detection of chemical markers in petroleum products | AUTHENTIC INC. (US) | 2007-04-24 | — | — | US | disclosed |
| WO-2005099689-A1 | TOPICAL DELIVERY OF PHTHALOCYANINES | CASE WESTERN RESERVE UNIVERSITY (US) | 2005-10-27 | — | — | WO | disclosed |
| US-20040147413-A1 | IMS detection of chemical markers in petroleum products | AUTHENTIX, INC. | 2004-07-29 | — | — | US | disclosed |
| US-20020187562-A1 | Materials for separating and detecting enantiomers of amphetamine or methamphetamine, and their application | LUA AHAI-CHANG (TW) | 2002-12-12 | — | — | US | disclosed |
| WO-1993023570-A1 | OLIGONUCLEOTIDES HAVING CONJUGATES ATTACHED AT THE 2'-POSITION OF THE SUGAR MOIETY | PHARMAGENICS, INC. (US) | 1993-11-25 | — | — | WO | disclosed |
| EP-0462980-A4 | PLATINUM PHARMACEUTICAL AGENTS | — | 1992-03-11 | — | — | EP | disclosed |
| EP-0462980-A1 | PLATINUM PHARMACEUTICAL AGENTS | GEORGETOWN UNIVERSITY (US) | 1992-01-02 | — | — | EP | disclosed |
| US-4946954-A | ANTICARCINOGENIC AGENTS | GEORGETOWN UNIVERSITY (US) | 1990-08-07 | — | — | US | disclosed |
| WO-1990008157-A1 | PLATINUM PHARMACEUTICAL AGENTS | GEORGETOWN UNIVERSITY (US) | 1990-07-26 | — | — | WO | disclosed |
| US-4895936-A | Water soluble anticancer agents | GEORGETOWN UNIVERSITY (US) | 1990-01-23 | — | — | US | disclosed |
| US-4895935-A | ANTITUMOR | GEORGETOWN UNIVERSITY (US) | 1990-01-23 | — | — | US | disclosed |
| US-4025622-A | ANTIBACTERIAL | Ogura, Haruo (JA) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110262977-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINE DERIVATIVE | PADI4, INMT, SMS | CYP2D6 523/4885THRB 3343/4885HSD17B10 2196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.